S 1618 NY

0likes☆Favorite🔕SubscribeShare

Passed Legislature

Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.

• Gustavo Rivera Democratic · primary

1. Jan 13, 2025 REFERRED TO HEALTH · upper
2. Jan 21, 2025 REPORTED AND COMMITTED TO FINANCE · upper
3. Apr 29, 2025 1ST REPORT CAL.750 · upper
4. Apr 30, 2025 2ND REPORT CAL. · upper
5. May 1, 2025 ADVANCED TO THIRD READING · upper
6. May 20, 2025 PASSED SENATE · upper
7. May 20, 2025 DELIVERED TO ASSEMBLY · upper
8. May 20, 2025 REFERRED TO HEALTH · lower
9. Jan 7, 2026 DIED IN ASSEMBLY · lower
10. Jan 7, 2026 RETURNED TO SENATE · lower
11. Jan 7, 2026 REFERRED TO HEALTH · upper
12. Feb 4, 2026 REPORTED AND COMMITTED TO FINANCE · upper
13. Feb 9, 2026 COMMITTEE DISCHARGED AND COMMITTED TO RULES · upper
14. Feb 9, 2026 ORDERED TO THIRD READING CAL.293 · upper
15. Feb 24, 2026 PASSED SENATE · upper
16. Feb 24, 2026 DELIVERED TO ASSEMBLY · upper
17. Feb 24, 2026 REFERRED TO HEALTH · lower

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

• S1618 · HTML
• S1618 · PDF